Even in elevated-GMAb HP patients, significantly higher serum levels of KL-6, SP-D, CEA, CYFRA, and higher lymphocyte count in BAL were observed than in low-GMAb patients. This evidence concerns the gene SFTPD and hypersensitivity pneumonitis.